bluebird bio Inc

The Cambridge, Massachusetts-based clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic diseases and cancer. Its integrated product platforms encompass gene therapy, cancer immunotherapy and gene editing – providing it with the potential to treat, and hopefully cure, a broad range of serious diseases.